<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation created="27/10/2006" creator="Noriko Katsu" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=10347175"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>10347175</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term sem="Protein_molecule" id="T1" lex="SLP-76">SLP-76</term> and <term sem="Protein_molecule" id="T2" lex="Vav">Vav</term> function in separate, but overlapping pathways to augment <term sem="Other" id="T3" lex="interleukin-2_promoter_activity"><term sem="DNA_domain_or_region" id="T4" lex="interleukin-2_promoter"><term sem="Protein_molecule" id="T5" lex="interleukin-2">interleukin-2</term> promoter</term> activity</term>.</sentence>
<event id="E4">
<type class="Positive_regulation" />
<theme idref="T4" />
<cause idref="T1" />
<clue>SLP-76 and Vav <clueType>function</clueType> in separate, but overlapping pathways <clueType>to augment</clueType> interleukin-2 promoter activity.</clue>
</event>
<event id="E5">
<type class="Positive_regulation" />
<theme idref="T4" />
<cause idref="T2" />
<clue>SLP-76 and Vav <clueType>function</clueType> in separate, but overlapping pathways <clueType>to augment</clueType> interleukin-2 promoter activity.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term sem="Protein_molecule" id="T6" lex="SLP-76">SLP-76</term> and <term sem="Protein_molecule" id="T7" lex="Vav">Vav</term>, two <term sem="Protein_molecule" id="T8" lex="hematopoietic_cell_specific_molecule">hematopoietic cell specific molecules</term>, are critical for <term sem="Other" id="T9" lex="T_cell_development"><term sem="Cell_natural" id="A1">T cell</term> development</term> and activation.</sentence>
<event id="E7">
<type class="Positive_regulation" />
<theme idref="E11" />
<cause idref="T6" />
<clue>SLP-76 and Vav, two hematopoietic cell specific molecules, are <clueType>critical</clueType> <linkTheme>for</linkTheme> T cell development and activation.</clue>
</event>
<event id="E8">
<type class="Positive_regulation" />
<theme idref="E11" />
<cause idref="T7" />
<clue>SLP-76 and Vav, two hematopoietic cell specific molecules, are <clueType>critical</clueType> <linkTheme>for</linkTheme> T cell development and activation.</clue>
</event>
<event id="E9">
<type class="Positive_regulation" />
<theme idref="E12" />
<cause idref="T6" />
<clue>SLP-76 and Vav, two hematopoietic cell specific molecules, are <clueType>critical</clueType> <linkTheme>for</linkTheme> T cell development and activation.</clue>
</event>
<event id="E10">
<type class="Positive_regulation" />
<theme idref="E12" />
<cause idref="T7" />
<clue>SLP-76 and Vav, two hematopoietic cell specific molecules, are <clueType>critical</clueType> <linkTheme>for</linkTheme> T cell development and activation.</clue>
</event>
<event id="E11">
<type class="Cell_differentiation" />
<theme idref="A1" />
<clue>SLP-76 and Vav, two hematopoietic cell specific molecules, are critical for T cell <clueType>development</clueType> and activation.</clue>
</event>
<event id="E12">
<type class="Physiological_process" />
<theme idref="A1" />
<clue>SLP-76 and Vav, two hematopoietic cell specific molecules, are critical for T cell development and <clueType>activation</clueType>.</clue>
</event>
<sentence id="S3">Following <term sem="Other" id="T10" lex="T_cell_antigen_receptor_stimulation"><term sem="Protein_family_or_group" id="T11" lex="T_cell_antigen_receptor">T cell antigen receptor</term> stimulation</term>, <term sem="Protein_molecule" id="T12" lex="SLP-76">SLP-76</term> and <term sem="Protein_molecule" id="T13" lex="Vav">Vav</term> both undergo <term sem="Other" id="T14" lex="tyrosine_phosphorylation"><term sem="Amino_acid_monomer" id="T15" lex="tyrosine">tyrosine</term> phosphorylation</term> and associate with each other via the <term sem="Protein_domain_or_region" id="A2">SH2 domain of <term sem="Protein_molecule" id="T16" lex="Vav">Vav</term></term> and <term sem="Amino_acid_monomer" id="A3">phosphorylated <term sem="Amino_acid_monomer" id="T17" lex="tyrosine">tyrosines</term> of <term sem="Protein_molecule" id="T18" lex="SLP-76">SLP-76</term></term>.</sentence>
<event id="E13">
<type class="Physiological_process" />
<theme idref="A1" />
<cause idref="T11" />
<clue>Following T cell antigen receptor <clueType>stimulation</clueType>, SLP-76 and Vav both undergo tyrosine phosphorylation and associate with each other via the SH2 domain of Vav and phosphorylated tyrosines of SLP-76.</clue>
<comment>NO COREFTHEME</comment></event>
<event id="E14">
<type class="Protein_amino_acid_phosphorylation" />
<theme idref="T12" />
<site idref="T15" />
<clue>Following T cell antigen receptor stimulation, SLP-76 and Vav both undergo tyrosine <clueType>phosphorylation</clueType> and associate with each other via the SH2 domain of Vav and phosphorylated tyrosines of SLP-76.</clue>
</event>
<event id="E15">
<type class="Protein_amino_acid_phosphorylation" />
<theme idref="T13" />
<site idref="T15" />
<clue>Following T cell antigen receptor stimulation, SLP-76 and Vav both undergo tyrosine <clueType>phosphorylation</clueType> and associate with each other via the SH2 domain of Vav and phosphorylated tyrosines of SLP-76.</clue>
</event>
<event id="E16">
<type class="Positive_regulation" />
<theme idref="E14" />
<cause idref="E13" />
<clue><linkCause>Following</linkCause> T cell antigen receptor stimulation, SLP-76 and Vav both undergo tyrosine phosphorylation and associate with each other via the SH2 domain of Vav and phosphorylated tyrosines of SLP-76.</clue>
<comment>NO CLUETYPE</comment></event>
<event id="E17">
<type class="Positive_regulation" />
<theme idref="E15" />
<cause idref="E13" />
<clue><linkCause>Following</linkCause> T cell antigen receptor stimulation, SLP-76 and Vav both undergo tyrosine phosphorylation and associate with each other via the SH2 domain of Vav and phosphorylated tyrosines of SLP-76.</clue>
<comment>NO CLUETYPE</comment></event>
<event id="E18">
<type class="Binding" />
<theme idref="A2" />
<theme idref="A3" />
<clue>Following T cell antigen receptor stimulation, SLP-76 and Vav both undergo tyrosine phosphorylation and <clueType>associate</clueType> with each other <linkTheme>via</linkTheme> the SH2 domain of Vav and phosphorylated tyrosines of SLP-76.</clue>
<comment>TPS: A2; TPS: A3, OK</comment></event>
<event id="E19">
<type class="Protein_amino_acid_phosphorylation" />
<theme idref="T18" />
<site idref="T17" />
<clue>Following T cell antigen receptor stimulation, SLP-76 and Vav both undergo tyrosine phosphorylation and associate with each other via the SH2 domain of Vav and <clueType>phosphorylated</clueType> tyrosines <linkTheme>of</linkTheme> SLP-76.</clue>
</event>
<sentence id="S4">Furthermore, <term sem="Protein_molecule" id="T19" lex="SLP-76">SLP-76</term> and <term sem="Protein_molecule" id="T20" lex="Vav">Vav</term> have a synergistic effect on <term sem="Other" id="T21" lex="interleukin_(IL)-2_promoter_activity"><term sem="DNA_domain_or_region" id="T22" lex="interleukin_(IL)-2_promoter">interleukin (IL)-2 promoter</term> activity</term> in <term sem="Cell_cultured" id="T23" lex="T_cell">T cells</term>.</sentence>
<event id="E20">
<type class="Positive_regulation" />
<theme idref="T22" />
<cause idref="T19" />
<cause idref="T20" />
<clue>Furthermore, SLP-76 and Vav have a <clueType>synergistic effect</clueType> <linkTheme>on</linkTheme> interleukin (IL)-2 promoter activity in T cells.</clue>
</event>
<sentence id="S5">In this report, we show that two <term sem="Amino_acid_monomer" id="T24" lex="tyrosine">tyrosines</term>, <term sem="Amino_acid_monomer" id="T25" lex="Tyr-113">Tyr-113</term> and <term sem="Amino_acid_monomer" id="T26" lex="Tyr-128">Tyr-128</term>, of <term sem="Protein_molecule" id="T27" lex="SLP-76">SLP-76</term> are required for its binding to <term sem="Protein_molecule" id="T28" lex="Vav">Vav</term>, both in vitro and in <term sem="Cell_natural" id="T29" lex="intact_cell">intact cells</term>.</sentence>
<event id="E21">
<type class="Binding" />
<theme idref="T27" />
<theme idref="T28" />
<clue>In this report, we show that two tyrosines, Tyr-113 and Tyr-128, of SLP-76 are required for <corefTheme>its</corefTheme> <clueType>binding</clueType> <linkTheme>to</linkTheme> Vav, both <clueLoc>in vitro and in intact cells</clueLoc>.</clue>
</event>
<event id="E22">
<type class="Regulation" />
<theme idref="E21" />
<cause idref="T25" />
<clue>In this report, we show that two tyrosines, Tyr-113 and Tyr-128, <clueLoc>of SLP-76</clueLoc> are <clueType>required</clueType> <linkTheme>for</linkTheme> its binding to Vav, both in vitro and in intact cells.</clue>
</event>
<event id="E23">
<type class="Regulation" />
<theme idref="E21" />
<cause idref="T26" />
<clue>In this report, we show that two tyrosines, Tyr-113 and Tyr-128, <clueLoc>of SLP-76</clueLoc> are <clueType>required</clueType> <linkTheme>for</linkTheme> its binding to Vav, both in vitro and in intact cells.</clue>
</event>
<sentence id="S6">Surprisingly, we find also that the interaction between <term sem="Protein_molecule" id="T30" lex="SLP-76">SLP-76</term> and <term sem="Protein_molecule" id="T31" lex="Vav">Vav</term> is not required for their cooperation in augmenting <term sem="Other" id="T32" lex="IL-2_promoter_activity"><term sem="DNA_domain_or_region" id="T33" lex="IL-2_promoter"><term sem="Protein_molecule" id="T34" lex="IL-2">IL-2</term> promoter</term> activity</term>, as the two molecules appear to function in different signaling pathways upstream of <term sem="Other" id="T35" lex="IL-2_gene_expression"><term sem="DNA_domain_or_region" id="T36" lex="IL-2_gene"><term sem="Protein_molecule" id="T37" lex="IL-2">IL-2</term> gene</term> expression</term>.</sentence>
<event id="E24">
<type class="Binding" />
<theme idref="T30" />
<theme idref="T31" />
<clue>Surprisingly, we find also that the <clueType>interaction</clueType> <linkTheme>between</linkTheme> SLP-76 and Vav is not required for their cooperation in augmenting IL-2 promoter activity, as the two molecules appear to function in different signaling pathways upstream of IL-2 gene expression.</clue>
</event>
<event assertion="non-exist" id="E25">
<type class="Positive_regulation" />
<theme idref="E26" />
<cause idref="E24" />
<clue>Surprisingly, we find also that the interaction between SLP-76 and Vav is not <clueType>required</clueType> <linkTheme>for</linkTheme> their cooperation in augmenting IL-2 promoter activity, as the two molecules appear to function in different signaling pathways upstream of IL-2 gene expression.</clue>
</event>
<event id="E26">
<type class="Positive_regulation" />
<theme idref="T33" />
<cause idref="T30" />
<cause idref="T31" />
<clue>Surprisingly, we find also that the interaction between SLP-76 and Vav is not required for <corefCause>their</corefCause> <clueType>cooperation in augmenting</clueType> IL-2 promoter activity, as the two molecules appear to function in different signaling pathways upstream of IL-2 gene expression.</clue>
</event>
<event uncertainty="probable" id="E27">
<type class="Cell_communication" />
<theme idref="T30" />
<clue>Surprisingly, we find also that the interaction between SLP-76 and Vav is not required for their cooperation in augmenting IL-2 promoter activity, as <corefCause>the two molecules</corefCause> appear to <clueType>function in different signaling pathways</clueType> upstream of IL-2 gene expression.</clue>
</event>
<event uncertainty="probable" id="E28">
<type class="Cell_communication" />
<theme idref="T31" />
<clue>Surprisingly, we find also that the interaction between SLP-76 and Vav is not required for their cooperation in augmenting IL-2 promoter activity, as <corefCause>the two molecules</corefCause> appear to <clueType>function in different signaling pathways</clueType> upstream of IL-2 gene expression.</clue>
</event>
<event id="E29">
<type class="Positive_regulation" />
<theme idref="E31" />
<cause idref="E27" />
<clue>Surprisingly, we find also that the interaction between SLP-76 and Vav is not required for their cooperation in augmenting IL-2 promoter activity, as the two molecules appear to function in different signaling pathways <clueType>upstream</clueType> <linkTheme>of</linkTheme> IL-2 gene expression.</clue>
</event>
<event id="E30">
<type class="Positive_regulation" />
<theme idref="E31" />
<cause idref="E28" />
<clue>Surprisingly, we find also that the interaction between SLP-76 and Vav is not required for their cooperation in augmenting IL-2 promoter activity, as the two molecules appear to function in different signaling pathways <clueType>upstream</clueType> <linkTheme>of</linkTheme> IL-2 gene expression.</clue>
</event>
<event id="E31">
<type class="Gene_expression" />
<theme idref="T37" />
<clue>Surprisingly, we find also that the interaction between SLP-76 and Vav is not required for their cooperation in augmenting IL-2 promoter activity, as the two molecules appear to function in different signaling pathways upstream of IL-2 <clueType>gene expression</clueType>.</clue>
</event>
<sentence id="S7">Overexpression of <term sem="Protein_molecule" id="T38" lex="SLP-76">SLP-76</term> in the <term sem="Cell_cultured" id="T39" lex="Jurkat_T_cell_line">Jurkat T cell line</term> potentiates the activities of both <term sem="Protein_molecule" id="T40" lex="nuclear_factor_of_activated_T_cells">nuclear factor of activated T cells</term> and <term sem="Protein_family_or_group" id="T41" lex="AP-1_transcription_factor">AP-1 transcription factors</term>.</sentence>
<event id="E32">
<type class="Gene_expression" />
<theme idref="T38" />
<clue><clueType>Overexpression</clueType> <linkTheme>of</linkTheme> SLP-76 in the Jurkat T cell line potentiates the activities of both nuclear factor of activated T cells and AP-1 transcription factors.</clue>
</event>
<event id="E33">
<type class="Positive_regulation" />
<theme idref="E32" />
<clue><clueType>Overexpression</clueType> of SLP-76 in the Jurkat T cell line potentiates the activities of both nuclear factor of activated T cells and AP-1 transcription factors.</clue>
</event>
<event id="E34">
<type class="Positive_regulation" />
<theme idref="T40" />
<cause idref="E33" />
<clue>Overexpression of SLP-76 in the Jurkat T cell line <clueType>potentiates the activities</clueType> <linkTheme>of</linkTheme> both nuclear factor of activated T cells and AP-1 transcription factors.</clue>
</event>
<event id="E35">
<type class="Positive_regulation" />
<theme idref="T41" />
<cause idref="E33" />
<clue>Overexpression of SLP-76 in the Jurkat T cell line <clueType>potentiates the activities</clueType> <linkTheme>of</linkTheme> both nuclear factor of activated T cells and AP-1 transcription factors.</clue>
</event>
<sentence id="S8">In contrast, overexpression of <term sem="Protein_molecule" id="T42" lex="Vav">Vav</term> leads to enhanced <term sem="Other" id="T43" lex="nuclear_factor_of_activated_T_cells_activity"><term sem="Protein_molecule" id="T44" lex="nuclear_factor_of_activated_T_cells">nuclear factor of activated T cells</term> activity</term> without affecting <term sem="Protein_molecule" id="T45" lex="AP-1">AP-1</term>.</sentence>
<event id="E36">
<type class="Gene_expression" />
<theme idref="T42" />
<clue>In contrast, <clueType>overexpression</clueType> <linkTheme>of</linkTheme> Vav leads to enhanced nuclear factor of activated T cells activity without affecting AP-1.</clue>
</event>
<event id="E37">
<type class="Positive_regulation" />
<theme idref="E36" />
<clue>In contrast, <clueType>overexpression</clueType> of Vav leads to enhanced nuclear factor of activated T cells activity without affecting AP-1.</clue>
</event>
<event id="E38">
<type class="Positive_regulation" />
<theme idref="T44" />
<cause idref="E37" />
<clue>In contrast, overexpression of Vav <clueType>leads to enhanced</clueType> nuclear factor of activated T cells activity without affecting AP-1.</clue>
</event>
<event assertion="non-exist" id="E39">
<type class="Regulation" />
<theme idref="T45" />
<cause idref="E37" />
<clue>In contrast, overexpression of Vav leads to enhanced nuclear factor of activated T cells activity <clueType>without affecting</clueType> AP-1.</clue>
</event>
<sentence id="S9">Additionally, overexpression of <term sem="Protein_molecule" id="T46" lex="Vav">Vav</term>, but not <term sem="Protein_molecule" id="T47" lex="SLP-76">SLP-76</term>, augments <term sem="Protein_molecule" id="A4">CD28</term>-induced <term sem="Other" id="T49" lex="IL-2_promoter_activity"><term sem="DNA_domain_or_region" id="T50" lex="IL-2_promoter"><term sem="Protein_molecule" id="T51" lex="IL-2">IL-2</term> promoter</term> activity</term>.</sentence>
<event id="E40">
<type class="Gene_expression" />
<theme idref="T46" />
<clue>Additionally, <clueType>overexpression</clueType> <linkTheme>of</linkTheme> Vav, but not SLP-76, augments CD28-induced IL-2 promoter activity.</clue>
</event>
<event id="E41">
<type class="Positive_regulation" />
<theme idref="E40" />
<clue>Additionally, <clueType>overexpression</clueType> of Vav, but not SLP-76, augments CD28-induced IL-2 promoter activity.</clue>
</event>
<event id="E42">
<type class="Gene_expression" />
<theme idref="T47" />
<clue>Additionally, <clueType>overexpression</clueType> <linkTheme>of</linkTheme> Vav, but not SLP-76, augments CD28-induced IL-2 promoter activity.</clue>
</event>
<event id="E43">
<type class="Positive_regulation" />
<theme idref="E42" />
<clue>Additionally, <clueType>overexpression</clueType> of Vav, but not SLP-76, augments CD28-induced IL-2 promoter activity.</clue>
</event>
<event id="E44">
<type class="Positive_regulation" />
<theme idref="E46" />
<cause idref="E41" />
<clue>Additionally, overexpression of Vav, but not SLP-76, <clueType>augments</clueType> CD28-induced IL-2 promoter activity.</clue>
</event>
<event assertion="non-exist" id="E45">
<type class="Positive_regulation" />
<theme idref="E46" />
<cause idref="E43" />
<clue>Additionally, overexpression of Vav, but not SLP-76, <clueType>augments</clueType> CD28-induced IL-2 promoter activity.</clue>
</event>
<event id="E46">
<type class="Positive_regulation" />
<theme idref="T50" />
<cause idref="A4" />
<clue>Additionally, overexpression of Vav, but not SLP-76, augments CD28-<clueType>induced</clueType> IL-2 promoter activity.</clue>
<comment>NER: T48 del &quot;CD28-induced IL-2 promoter activity&quot;</comment></event>
<sentence id="S10">These findings suggest that the synergy between <term sem="Protein_molecule" id="T52" lex="SLP-76">SLP-76</term> and <term sem="Protein_molecule" id="T53" lex="Vav">Vav</term> in regulating <term sem="Other" id="T54" lex="IL-2_gene_expression"><term sem="DNA_domain_or_region" id="T55" lex="IL-2_gene"><term sem="Protein_molecule" id="T56" lex="IL-2">IL-2</term> gene</term> expression</term> reflects the cooperation between different <term sem="Other" id="T57" lex="signaling_pathway">signaling pathways</term>.</sentence>
<event id="E47">
<type class="Positive_regulation" />
<theme idref="E48" />
<cause idref="T52" />
<cause idref="T53" />
<clue>These findings suggest that the <clueType>synergy</clueType> <linkCause>between</linkCause> SLP-76 and Vav in <clueType>regulating</clueType> IL-2 gene expression reflects the cooperation between different signaling pathways.</clue>
</event>
<event id="E48">
<type class="Gene_expression" />
<theme idref="T56" />
<clue>These findings suggest that the synergy between SLP-76 and Vav in regulating IL-2 <clueType>gene expression</clueType> reflects the cooperation between different signaling pathways.</clue>
</event>
<event id="E50">
<type class="Regulation" />
<cause idref="T57" />
<cause idref="T57" />
<clue>These findings suggest that the synergy between SLP-76 and Vav in regulating IL-2 gene expression reflects the <clueType>cooperation</clueType> <linkCause>between</linkCause> different signaling pathways.</clue>
<comment>NO THEME</comment></event>
<event uncertainty="probable" id="E2">
<type class="Correlation" />
<theme idref="E47" />
<theme idref="E50" />
<clue>These findings suggest that the synergy between SLP-76 and Vav in regulating IL-2 gene expression <clueType>reflects</clueType> the cooperation between different signaling pathways.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
